The patient developed disease progression during postoperative adjuvant chemotherapy and rapidly progressed after tegafur-gimeracil-oteracil potassium capsules combined with apatinib, which was ...

This condition had progressed more than before (Figure 2A1–8), and it was assessed to be unresectable. On November 26 and December 31, 2019, two cycles of paclitaxel 400 mg D1, cisplatin 140 mg D1, ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...